Extensive Co-Operation between the Epstein-Barr Virus EBNA3 Proteins in the Manipulation of Host Gene Expression and Epigenetic Chromatin Modification

Epstein-Barr virus (EBV) is able to drive the transformation of B-cells, resulting in the generation of lymphoblastoid cell lines (LCLs) in vitro. EBV nuclear proteins EBNA3A and EBNA3C are necessary for efficient transformation, while EBNA3B is dispensable. We describe a transcriptome analysis of BL31 cells infected with a series of EBNA3-knockout EBVs, including one deleted for all three EBNA3 genes. Using Affymetrix Exon 1.0 ST microarrays analysed with the MMBGX algorithm, we have identified over 1000 genes whose regulation by EBV requires one of the EBNA3s. Remarkably, a third of the genes identified require more than one EBNA3 for their regulation, predominantly EBNA3C co-operating with either EBNA3B, EBNA3A or both. The microarray was validated by real-time PCR, while ChIP analysis of a selection of co-operatively repressed promoters indicates a role for polycomb group complexes. Targets include genes involved in apoptosis, cell migration and B-cell differentiation, and show a highly significant but subtle alteration in genes involved in mitosis. In order to assess the relevance of the BL31 system to LCLs, we analysed the transcriptome of a set of EBNA3B knockout (3BKO) LCLs. Around a third of the genes whose expression level in LCLs was altered in the absence of EBNA3B were also altered in 3BKO-BL31 cell lines. Among these are TERT and TCL1A, implying that EBV-induced changes in the expression of these genes are not required for B-cell transformation. We also identify 26 genes that require both EBNA3A and EBNA3B for their regulation in LCLs. Together, this shows the complexity of the interaction between EBV and its host, whereby multiple EBNA3 proteins co-operate to modulate the behaviour of the host cell.

[1]  Sung-Mi Shim,et al.  Expression phenotype changes of EBV‐transformed lymphoblastoid cell lines during long‐term subculture and its clinical significance , 2010, Cell proliferation.

[2]  Robert E. White,et al.  Epigenetic Repression of p16INK4A by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP , 2010, PLoS pathogens.

[3]  R. Sompallae,et al.  Three Epstein–Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints , 2009, Oncogene.

[4]  S. Pillai,et al.  The follicular versus marginal zone B lymphocyte cell fate decision , 2009, Nature Reviews Immunology.

[5]  Kristian Helin,et al.  Polycomb group proteins: navigators of lineage pathways led astray in cancer , 2009, Nature Reviews Cancer.

[6]  Alex Lewin,et al.  MMBGX: a method for estimating expression at the isoform level and detecting differential splicing using whole-transcript Affymetrix arrays , 2009, Nucleic acids research.

[7]  Robert E. Kingston,et al.  Mechanisms of Polycomb gene silencing: knowns and unknowns , 2009, Nature Reviews Molecular Cell Biology.

[8]  M. Calderwood,et al.  Epstein-Barr Virus Nuclear Protein 3C Domains Necessary for Lymphoblastoid Cell Growth: Interaction with RBP-Jκ Regulates TCL1 , 2009, Journal of Virology.

[9]  Sourav Bandyopadhyay,et al.  Evolutionarily Conserved Herpesviral Protein Interaction Networks , 2009, PLoS pathogens.

[10]  E. Kremmer,et al.  Differential Gene Expression Patterns of EBV Infected EBNA-3A Positive and Negative Human B Lymphocytes , 2009, PLoS pathogens.

[11]  E. Robertson,et al.  Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. , 2009, Virology.

[12]  Robert E. White,et al.  Epstein-Barr Virus Latency in B Cells Leads to Epigenetic Repression and CpG Methylation of the Tumour Suppressor Gene Bim , 2009, PLoS pathogens.

[13]  B. Blom,et al.  New insights into the regulation of human B-cell differentiation. , 2009, Trends in immunology.

[14]  E. Robertson,et al.  Epstein-Barr Virus Nuclear Antigen 3C Augments Mdm2-Mediated p53 Ubiquitination and Degradation by Deubiquitinating Mdm2 , 2009, Journal of Virology.

[15]  D. Thorley-Lawson,et al.  The Intersection of Epstein-Barr Virus with the Germinal Center , 2009, Journal of Virology.

[16]  D. Thorley-Lawson,et al.  The curious case of the tumour virus: 50 years of Burkitt's lymphoma , 2008, Nature Reviews Microbiology.

[17]  D. Allman,et al.  Transcriptional regulation of early B cell development , 2008, Immunologic research.

[18]  H. Spits,et al.  T cell–independent development and induction of somatic hypermutation in human IgM+IgD+CD27+ B cells , 2008, The Journal of experimental medicine.

[19]  A. De Rossi,et al.  Latent Membrane Protein 1 of Epstein-Barr Virus Activates the hTERT Promoter and Enhances Telomerase Activity in B Lymphocytes , 2008, Journal of Virology.

[20]  S. Swaminathan Noncoding RNAs produced by oncogenic human herpesviruses , 2008, Journal of cellular physiology.

[21]  W. Lucchesi,et al.  Differential Gene Regulation by Epstein-Barr Virus Type 1 and Type 2 EBNA2 , 2008, Journal of Virology.

[22]  Robert E. White,et al.  Epstein–Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones , 2008, The Journal of general virology.

[23]  Kyoko Ochiai,et al.  Regulation of the plasma cell transcription factor Blimp-1 gene by Bach2 and Bcl6. , 2008, International immunology.

[24]  Robert E. White,et al.  Two Epstein–Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma , 2008, Oncogene.

[25]  B. Stollar,et al.  Influence of EBV on the Peripheral Blood Memory B Cell Compartment1 , 2007, The Journal of Immunology.

[26]  M. Masucci,et al.  Epstein–Barr virus promotes genomic instability in Burkitt's lymphoma , 2007, Oncogene.

[27]  A. Vazquez,et al.  Epstein–Barr virus and virus human protein interaction maps , 2007, Proceedings of the National Academy of Sciences.

[28]  B. Han,et al.  Identification of stathmin 1 expression induced by Epstein–Barr virus in human B lymphocytes , 2007, Cell proliferation.

[29]  T. Kanda,et al.  Epstein–Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells , 2006, Proceedings of the National Academy of Sciences.

[30]  E. Kieff,et al.  EBNA-3B- and EBNA-3C-Regulated Cellular Genes in Epstein-Barr Virus-Immortalized Lymphoblastoid Cell Lines , 2006, Journal of Virology.

[31]  A. Hartmann,et al.  Cellular Target Genes of Epstein-Barr Virus Nuclear Antigen 2 , 2006, Journal of Virology.

[32]  W. Lucchesi,et al.  Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells. , 2006, The Journal of general virology.

[33]  James A. Cuff,et al.  A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.

[34]  T. Sculley,et al.  Nuclear localization of the Epstein-Barr virus EBNA3B protein. , 2006, The Journal of general virology.

[35]  E. Robertson,et al.  Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  E. Kieff,et al.  Mediation of Epstein–Barr virus EBNA‐LP transcriptional coactivation by Sp100 , 2005, The EMBO journal.

[37]  M. Allday,et al.  Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells. , 2005, The Journal of general virology.

[38]  Xiaoqun Jiang,et al.  Epstein-Barr Virus with the Latent Infection Nuclear Antigen 3B Completely Deleted Is Still Competent for B-Cell Growth Transformation In Vitro , 2005, Journal of Virology.

[39]  E. Robertson,et al.  SCFSkp2 Complex Targeted by Epstein-Barr Virus Essential Nuclear Antigen , 2005, Molecular and Cellular Biology.

[40]  E. Robertson,et al.  A Cyclin-Binding Motif within the Amino-Terminal Homology Domain of EBNA3C Binds Cyclin A and Modulates Cyclin A-Dependent Kinase Activity in Epstein-Barr Virus-Infected Cells , 2004, Journal of Virology.

[41]  L. Young,et al.  Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.

[42]  X. Deng,et al.  Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells. , 2004, Journal of experimental & clinical cancer research : CR.

[43]  T. Ide,et al.  Steps Involved in Immortalization and Tumorigenesis in Human B-Lymphoblastoid Cell Lines Transformed by Epstein-Barr Virus , 2004, Cancer Research.

[44]  D. Thorley-Lawson,et al.  Persistence of the Epstein-Barr virus and the origins of associated lymphomas. , 2004, The New England journal of medicine.

[45]  E. Robertson,et al.  Epstein-Barr Virus Nuclear Antigen 3C Regulates Cyclin A/p27 Complexes and Enhances Cyclin A-Dependent Kinase Activity , 2004, Journal of Virology.

[46]  T. Sculley,et al.  The Epstein-Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein. , 2004, Virology.

[47]  Robert E. White,et al.  Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence. , 2003, The Journal of general virology.

[48]  L. Young,et al.  Epstein–Barr virus and oncogenesis: from latent genes to tumours , 2003, Oncogene.

[49]  E. Robertson,et al.  Epstein-Barr Virus Nuclear Antigen 3C Recruits Histone Deacetylase Activity and Associates with the Corepressors mSin3A and NCoR in Human B-Cell Lines , 2003, Journal of Virology.

[50]  Andrea Califano,et al.  Transcriptional analysis of the B cell germinal center reaction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Freemont,et al.  Two Nonconsensus Sites in the Epstein-Barr Virus Oncoprotein EBNA3A Cooperate to Bind the Co-repressor Carboxyl-terminal-binding Protein (CtBP)* , 2002, The Journal of Biological Chemistry.

[52]  W. Hammerschmidt,et al.  Glycoprotein gp110 of Epstein–Barr virus determines viral tropism and efficiency of infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  L. Strobl,et al.  EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. , 2001, Seminars in cancer biology.

[54]  T. Crook,et al.  Physical and Functional Interactions between the Corepressor CtBP and the Epstein-Barr Virus Nuclear Antigen EBNA3C , 2001, Journal of Virology.

[55]  D. Crawford,et al.  Biology and disease associations of Epstein-Barr virus. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[56]  G. Parker,et al.  Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis , 2000, Oncogene.

[57]  M. Wade,et al.  Epstein-Barr Virus Suppresses a G2/M Checkpoint Activated by Genotoxins , 2000, Molecular and Cellular Biology.

[58]  T. Kouzarides,et al.  Epstein-Barr Virus Nuclear Antigen 3C Interacts with Histone Deacetylase To Repress Transcription , 1999, Journal of Virology.

[59]  R. Dalla‐Favera,et al.  Direct activation of TERT transcription by c-MYC , 1999, Nature Genetics.

[60]  W. Hammerschmidt,et al.  Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[61]  P. Farrell,et al.  Multiple Functions within the Epstein-Barr Virus EBNA-3A Protein , 1998, Journal of Virology.

[62]  L. Waltzer,et al.  Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa. , 1998, The Journal of general virology.

[63]  P. Farrell,et al.  Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21 , 1997, Journal of virology.

[64]  A. Rickinson,et al.  Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain , 1997, Journal of virology.

[65]  E. Kieff,et al.  Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation , 1997, Journal of virology.

[66]  T. Crook,et al.  Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. , 1996, Oncogene.

[67]  M. Perricaudet,et al.  Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA , 1996, Journal of virology.

[68]  R. Watson,et al.  Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA , 1996, Journal of virology.

[69]  C. Sample,et al.  Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator , 1995, Journal of virology.

[70]  B. Leber,et al.  Telomerase activity in normal leukocytes and in hematologic malignancies. , 1995, Blood.

[71]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa , 1995, Journal of virology.

[72]  E. Kremmer,et al.  Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B). , 1995, Virology.

[73]  M. Perricaudet,et al.  The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. , 1994, Virology.

[74]  P. Ling,et al.  Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. , 1994, Science.

[75]  E. Kieff,et al.  Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation , 1993, Journal of virology.

[76]  E. Kieff,et al.  Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro , 1992, Journal of virology.

[77]  D. Rowe,et al.  Size and stability of the Epstein-Barr virus major internal repeat (IR-1) in Burkitt's lymphoma and lymphoblastoid cell lines. , 1989, Virology.

[78]  G. Lenoir,et al.  Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains , 1988, Journal of virology.

[79]  I. Ernberg,et al.  Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines , 1987, Journal of virology.

[80]  J. Banchereau,et al.  Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[81]  L. Young,et al.  Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells. , 1987, The EMBO journal.

[82]  E. Robertson Epstein-barr virus : latency and transformation , 2010 .

[83]  M. Allday,et al.  Deregulation of the cell cycle by the Epstein-Barr virus. , 2004, Advances in cancer research.